Palliative Sedation in End-of-Life Patients in Eastern Asia: A Narrative Review

다국어 초록 (Multilingual Abstract)

Although palliative sedation (PS) is a common practice in the palliative care of cancer patients in Western countries, there is little related research on the practice in Korea. PS can be classified into several categories according to sedation level and continuity. PS is clearly distinct from euthanasia. While euthanasia is illegal and regarded as unethical in Korea, there is little ethical and legal controversy about PS in terms of the doctrine of double effect. Most studies have asserted that PS does not shorten the survival of terminal cancer patients. Since preference for PS heavily depends on stakeholder value, it should be preceded by shared decision-making through full communication among the patient, family members, and medical team. This is a narrative review article analyzing previous studies, especially from the three Eastern Asian countries, Korea, Japan and Taiwan, which share similar cultures compared with Western countries. Practical issues concerning PS—for example, prevalence, type and dosage of medications, salvage medication, timing of its initiation, and assessment—are described in detail.

참고문헌 (Reference)

1 한지희 ; 천혜숙 ; 김태희 ; 김록범 ; 김정훈 ; 강정훈, "수정된 한글 연명의료계획서(Modified Korean Physician Order for Life-Sustaining Treatment, MK-POLST) 분석을 통한 호스피스 병동 환자의 의료 중재 항목별 선호도 및 충실도 조사" 한국호스피스완화의료학회 22 (22): 198-206, 2019

2 van Deijck RH, "The practice of continuous palliative sedation in long-term care for frail patients with existential suffering" 31 : 141-149, 2015

3 Belar A, "The decision-making process for palliative sedation for patients with advanced cancer-analysis from a systematic review of prospective studies" 14 : 301-, 2022

4 Teunissen SC, "Symptom prevalence in patients with incurable cancer : a systematic review" 34 : 94-104, 2007

5 Morita T, "Similarity and difference among standard medical care, palliative sedation therapy, and euthanasia : a multidimensional scaling analysis on physicians’ and the general population’s opinions" 25 : 357-362, 2003

6 Kim YS, "Sedation for terminally ill cancer patients : a multicenter retrospective cohort study in South Korea" 98 : e14278-, 2019

7 Schur S, "Sedation at the end of life : a nation-wide study in palliative care units in Austria" 15 : 50-, 2016

8 Twycross R, "Reflections on palliative sedation" 12 : 1178224218823511-, 2019

9 Eun Y, "Qualitative study on the perceptions of terminally ill cancer patients and their family members regarding end-of-life experiences focusing on palliative sedation" 53 : 1010-1016, 2017

10 Swart SJ, "Physicians’ and nurses’ experiences with continuous palliative sedation in the Netherlands" 170 : 1271-1274, 2010

11 Jackson WC, "Palliative sedation vs. terminal sedation: what’s in a name?" 19 : 81-82, 2002

12 Caraceni A, "Palliative sedation in terminal cancer patients admitted to hospice or home care programs : does the setting matter? Results from a national multicenter observational study" 56 : 33-43, 2018

13 Maltoni M, "Palliative sedation in patients with cancer" 22 : 433-441, 2015

14 Rodrigues P, "Palliative sedation for existential suffering : a systematic review of argument-based ethics literature" 55 : 1577-1590, 2018

15 Gurschick L, "Palliative sedation : an analysis of International Guidelines and Position Statements" 32 : 660-671, 2015

16 Bruinsma S, "Palliative sedation : a focus group study on the experiences of relatives" 16 : 349-355, 2013

17 Morita T, "Palliative care physicians’ attitudes toward patient autonomy and a good death in East Asian countries" 50 : 190-199, 2015

18 Hui D, "Neuroleptics in the management of delirium in patients with advanced cancer" 10 : 316-323, 2016

19 Schildmann EK, "Medication and monitoring in palliative sedation therapy : a systematic review and quality assessment of published guidelines" 49 : 734-746, 2015

20 Korean Society of Critical Care Medicine, "Korean professional consensus for comfort care and withdrawing/withholding in the intensive care unit"

21 Belar A, "How to measure the effects and potential adverse events of palliative sedation? An integrative review" 35 : 295-314, 2021

22 Setla J, "Home palliative sedation using phenobarbital suppositories : time to death, patient characteristics, and administration protocol" 36 : 871-876, 2019

23 Morita T, "Family experience with palliative sedation the-rapy for terminally ill cancer patients" 28 : 557-565, 2004

24 Morita T, "Efficacy and safety of palliative sedation therapy : a multicenter, prospective, observational study conducted on specialized palliative care units in Japan" 30 : 320-328, 2005

25 Hui D, "Effect of lorazepam with haloperidol vs haloperidol alone on agitated delirium in patients with advanced cancer receiving palliative care : a randomized clinical trial" 318 : 1047-1056, 2017

26 Yokomichi N, "Effect of continuous deep sedation on survival in the last days of life of cancer patients : a multicenter prospective cohort study" 36 : 189-199, 2022

27 Maeda I, "Effect of continuous deep sedation on survival in patients with advanced cancer(J-Proval) : a propensity score-weighted analysis of a prospective cohort study" 17 : 115-122, 2016

28 Shen HS, "Differential family experience of palliative sedation therapy in specialized palliative or critical care units" 55 : 1531-1539, 2018

29 Lipuma SH, "Continuous sedation until death as physician-assisted suicide/euthanasia : a conceptual analysis" 38 : 190-204, 2013

30 Morita T, "Concerns of family members of patients recei-ving palliative sedation therapy" 12 : 885-889, 2004

31 Yamaguchi T, "Communication and behavior of palliative care physicians of patients with cancer near end of life in three East Asian countries" 61 : 315-322, 2021

32 Won YW, "Clinical patterns of continuous and intermittent palliative sedation in patients with terminal cancer : a descriptive, observational study" 58 : 65-71, 2019

33 Fredheim OM, "Clinical and ethical aspects of palliative sedation with propofol : a retrospective quantitative and qualitative study" 64 : 1319-1326, 2020

34 신진영 ; Yoon Jung Chang ; So-Jung Park ; Jin Young Choi ; Sun-Hyun Kim ; 최윤선 ; Nam Hee Kim ; Ho-Kee Yum ; 남은미 ; 박명희 ; Nayeon Moon ; Jee Youn Moon ; 강희택 ; 강정훈 ; 박재민 ; Chung-Woo Lee ; 김선영 ; 이은정 ; 고수진 ; Yonghwan Kim ; Myongjin Agnes Cho ; 송유현 ; 심재용, "Clinical Practice Guideline for Care in the Last Days of Life" 한국호스피스완화의료학회 23 (23): 103-113, 2020

35 National Cancer Center, "Cancer pain management guideline" National Cancer Center 2019

36 Kendall CE, "At the coalface : medical ethics in practice : a double dose of double effect" 26 : 204-205, 2000

37 Elwyn G, "A three-talk model for shared decision making : multistage consultation process" 359 : j4891-, 2017

38 Bodnar J, "A review of agents for palliative sedation/continuous deep sedation : pharmacology and practical applications" 31 : 16-37, 2017

39 Sheldon T, ""Terminal sedation"different from euthanasia, Dutch ministers agree" 327 : 465-, 2003